Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03761225
Title Masitinib Plus Docetaxel in Metastatic Castration-resistant Prostate Cancer
Recruitment Active, not recruiting
Gender male
Phase Phase III
Variant Requirements No
Sponsors AB Science
Indications

prostate cancer

Therapies

Docetaxel + Prednisone

Docetaxel + Masitinib + Prednisone

Age Groups: adult | senior
Covered Countries CAN


No variant requirements are available.